Literature DB >> 3321075

Immunopathology of the skin lesion of Kawasaki disease.

T Sugawara1, S Hattori, S Hirose, S Furukawa, K Yabuta, T Shirai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3321075

Source DB:  PubMed          Journal:  Prog Clin Biol Res        ISSN： 0361-7742


× No keyword cloud information.
  10 in total

1.  CD14+CD16+ monocyte subpopulation in Kawasaki disease.

Authors:  K Katayama; T Matsubara; M Fujiwara; M Koga; S Furukawa
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

2.  Th1 and Th2 cytokine production is suppressed at the level of transcriptional regulation in Kawasaki disease.

Authors:  J Kimura; H Takada; A Nomura; T Ohno; Y Mizuno; M Saito; K Kusuhara; T Hara
Journal:  Clin Exp Immunol       Date:  2004-08       Impact factor: 4.330

3.  Serum soluble CD4 and CD8 levels in Kawasaki disease.

Authors:  S Furukawa; T Matsubara; K Tsuji; T Motohashi; K Okumura; K Yabuta
Journal:  Clin Exp Immunol       Date:  1991-10       Impact factor: 4.330

4.  Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease.

Authors:  Haruyuki Makata; Takashi Ichiyama; Ryutaro Uchi; Tsuyoshi Takekawa; Tomoyo Matsubara; Susumu Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08-01       Impact factor: 3.000

5.  Decreased interferon-gamma (IFN-gamma)-producing T cells in patients with acute Kawasaki disease.

Authors:  T Matsubara; K Katayama; T Matsuoka; M Fujiwara; M Koga; S Furukawa
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

6.  The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses.

Authors:  Y Ueno; N Takano; H Kanegane; T Yokoi; A Yachie; T Miyawaki; N Taniguchi
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

7.  Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin.

Authors:  S Furukawa; T Matsubara; K Jujoh; K Sasai; S Nakachi; T Sugawara; K Yabuta; H Kato
Journal:  Eur J Pediatr       Date:  1990-11       Impact factor: 3.183

8.  Kawasaki disease as a systemic vasculitis in childhood.

Authors:  Kei Takahashi; Toshiaki Oharaseki; Yuki Yokouchi; Nobuyuki Hiruta; Shiro Naoe
Journal:  Ann Vasc Dis       Date:  2010-12-02

9.  The "Intermediate" CD14 + CD16 + monocyte subpopulation plays a role in IVIG responsiveness of children with Kawasaki disease.

Authors:  Yi Seul Kim; Hyun Jin Yang; Seung-Jung Kee; Insu Choi; Kisoo Ha; Katrina K Ki; In Seok Jeong; Hwa Jin Cho
Journal:  Pediatr Rheumatol Online J       Date:  2021-05-31       Impact factor: 3.054

10.  Circulating Immune Cell Profile and Changes in Intravenous Immunoglobulin Responsiveness Over the Disease Course in Children With Kawasaki Disease.

Authors:  In Su Choi; Mi Ji Lee; Seul A Choi; Kyung Soon Choi; In Seok Jeong; Hwa Jin Cho
Journal:  Front Pediatr       Date:  2022-02-04       Impact factor: 3.418
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.